New Market Research Report: Cellular Tumor Antigen P53 - Pipeline Review, H2 2016
Global Markets Direct's, 'Cellular Tumor Antigen p53 (Tumor Suppressor p53 or Phosphoprotein p53 or Antigen NY CO 13 or TP53) - Pipeline Review, H2 2016', provides in depth analysis on Cellular Tumor Antigen p53 (Tumor Suppressor p53 or Phosphoprotein p53 or Antigen NY CO 13 or TP53) targeted pipeline therapeutics.
View full press release